Q1 FY2022 · Press release
3 pages
Read Alnylam Pharmaceuticals, Inc.'s results firsthand
Preview the first 2 pages of this press release
Create a free account to start reading
Full documents are included with Professional
Alnylam Pharmaceuticals, Inc.
165.00
USD
-9.00
(-5.17%)
